Current and historical daily PE Ratio for TSMRF (
Tsumura & Co
) from 2013 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Tsumura & stock (TSMRF) PE ratio as of Jun 19 2024 is 18.46.
More Details
Tsumura & Co (TSMRF) PE Ratio (TTM) Chart
Tsumura & Co (TSMRF) PE Ratio (TTM) Historical Data
View and export this data going back to 2013. Start your Free Trial
Total 1251
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Tsumura & PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-19 | 17.6 | 2024-04-16 | 17.0 |
2024-06-18 | 17.6 | 2024-04-15 | 17.0 |
2024-06-17 | 17.6 | 2024-04-12 | 17.0 |
2024-06-14 | 17.6 | 2024-04-11 | 17.0 |
2024-06-13 | 17.6 | 2024-04-10 | 17.0 |
2024-06-12 | 17.6 | 2024-04-09 | 17.0 |
2024-06-11 | 17.6 | 2024-04-08 | 17.0 |
2024-06-10 | 17.6 | 2024-04-05 | 17.0 |
2024-06-07 | 17.6 | 2024-04-04 | 17.0 |
2024-06-06 | 17.6 | 2024-04-03 | 17.0 |
2024-06-05 | 17.6 | 2024-04-02 | 17.0 |
2024-06-04 | 17.6 | 2024-04-01 | 17.0 |
2024-06-03 | 17.6 | 2024-03-28 | 17.0 |
2024-05-31 | 17.6 | 2024-03-27 | 16.9 |
2024-05-30 | 17.6 | 2024-03-26 | 16.9 |
2024-05-29 | 17.6 | 2024-03-25 | 16.9 |
2024-05-28 | 17.6 | 2024-03-22 | 16.9 |
2024-05-24 | 17.6 | 2024-03-21 | 16.9 |
2024-05-23 | 17.6 | 2024-03-20 | 15.2 |
2024-05-22 | 17.6 | 2024-03-19 | 15.2 |
2024-05-21 | 17.6 | 2024-03-18 | 15.2 |
2024-05-20 | 17.6 | 2024-03-15 | 15.2 |
2024-05-17 | 17.6 | 2024-03-14 | 15.2 |
2024-05-16 | 17.6 | 2024-03-13 | 15.2 |
2024-05-15 | 17.6 | 2024-03-12 | 15.2 |
2024-05-14 | 17.6 | 2024-03-11 | 15.2 |
2024-05-13 | 17.6 | 2024-03-08 | 15.2 |
2024-05-10 | 17.6 | 2024-03-07 | 15.2 |
2024-05-09 | 17.6 | 2024-03-06 | 15.2 |
2024-05-08 | 17.0 | 2024-03-05 | 12.3 |
2024-05-07 | 17.0 | 2024-03-04 | 12.3 |
2024-05-06 | 17.0 | 2024-03-01 | 12.3 |
2024-05-03 | 17.0 | 2024-02-29 | 12.3 |
2024-05-02 | 17.0 | 2024-02-28 | 12.3 |
2024-05-01 | 17.0 | 2024-02-27 | 12.3 |
2024-04-30 | 17.0 | 2024-02-26 | 12.3 |
2024-04-29 | 17.0 | 2024-02-23 | 12.3 |
2024-04-26 | 17.0 | 2024-02-22 | 12.3 |
2024-04-25 | 17.0 | 2024-02-21 | 12.3 |
2024-04-24 | 17.0 | 2024-02-20 | 12.3 |
2024-04-23 | 17.0 | 2024-02-16 | 12.3 |
2024-04-22 | 17.0 | 2024-02-15 | 12.3 |
2024-04-19 | 17.0 | 2024-02-14 | 12.3 |
2024-04-18 | 17.0 | 2024-02-13 | 12.3 |
2024-04-17 | 17.0 | 2024-02-12 | 12.3 |
Tsumura & Co (TSMRF) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Tsumura & Co
NAICS : 325412
SIC : 2834
ISIN : JP3535800001
Share Class Description:
TSMRF: Ordinary SharesDescription
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.